Breaking Finance News

Creston PLC (LON:CRE) has been reiterated to Buy in a statement by N+1 Singer earlier today.

N+1 Singer has reiterated Creston PLC (LON:CRE) to Buy in a statement released on 10/05/2016.

On 9/14/2016, Liberum Capital released a statement for Creston PLC (LON:CRE) maintained the target price at 170.00GBX that suggested an upside of 0.62%.

Boasting a price of 97.50GBX, Creston PLC (LON:CRE) traded -1.00% lower on the day. With the last stock price close down 1.97% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the date range. Creston PLC has recorded a 50-day average of 102.36GBX and a two hundred day average of 98.07GBX. Volume of trade was down over the average, with 27,550 shares of CRE changing hands under the typical 71,732

Performance Chart

Creston PLC (LON:CRE)

With a total market value of 0 GBX, Creston PLC has with a one year low of 83.60GBX and a one year high of 162.00GBX .

A total of 3 equity analysts have released a research note on CRE. One equity analyst rating the company a strong buy, one equity analyst rating the company a buy, one equity analyst rating the company a hold, zero equity analysts rating the company a underperform, and finally zero equity analysts rating the company a sell with a one year target of 134.67GBX.

More About Creston PLC (LON:CRE)

Creston plc is a marketing communications company delivering digital technology-based marketing solutions to a range of clients. The Company operates through two segments. The Communications & Insight segment's services include advertising, brand strategy, customer relationship marketing, digital and direct marketing, local marketing, market research using face-to-face, telephone and online data collection techniques, social media marketing and public relations. The Health segment provides integrated communications solutions to healthcare and pharmaceutical sector and offers services, which include advertising, advocacy, digital and direct marketing, public relations, issues and reputation management, and medical education. Its geographical segments include UK, Rest of Europe and Rest of the World (including US). Its subsidiaries include Colombus Communications Limited, Creston Connections Limited, Creston Unlimited Limited and Emery McLaven Orr Limited.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.